Training Physician-Scientists at the Elmezzi Graduate School of Molecular Medicine.
Photo: Courtesy of the Elmezzi Graduate School of Molecular Medicine
Training Physician-Scientists at the Elmezzi Graduate School of Molecular Medicine.
Photo: Courtesy of the Elmezzi Graduate School of Molecular Medicine

Elmezzi Graduate School of Molecular Medicine

The Elmezzi Graduate School of Molecular Medicine is a unique PhD program that trains physician-scientists to conduct state-of-the-art research. The goal is for these physician-scientists to discover and understand the causes of human diseases and translate their research into diagnostic and therapeutic solutions for patients. The students are exceptional graduate physicians from all parts of the world who have already completed their medical education. They are not charged tuition or other fees, and they receive a salary stipend while they conduct their research studies. Funds are provided by the school’s endowment, a significant portion of which is provided by the Elmezzi Foundation, and by The Feinstein Institute for Medical Research.

Results

The School admits 3 to 4 new students each year. To date, 28 students have graduated, and 97% have remained active in research. This is in contrast to traditional MD/PhD programs where students complete both degrees while in medical school, and where less than half of graduates continue to do research after completing their training.

Profile

Dr. Daniel Griffin was already a successful, award-wining physician when he entered the Elmezzi Graduate School. During his time in the program, he found a specialized white blood cell that scientists had been seeking for decades. The discovery of this unique human B lymphocyte and its important functioning was published in a leading scientific journal. Dan graduated in 2012 and is now continuing his research while enrolled in an Infectious Disease fellowship at the Hofstra North Shore-LIJ School of Medicine. His long-term goal is to use the knowledge he has gained to find better ways to treat patients with infections.